Yonggang Zhou

InstitutionGeneral Hospital of Chinese PLA
AddressChina
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in November 2020 and March 2021
    All Publications
    Bar chart showing 67 publications over 20 distinct years, with a maximum of 12 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhang J, Wu H, Yao X, Zhang D, Zhou Y, Fu B, Wang W, Li H, Wang Z, Hu Z, Ren Y, Sun R, Tian Z, Bian X, Wei H. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell Mol Immunol. 2021 05; 18(5):1305-1307. PMID: 33742186.
      Citations: 11     Fields:    Translation:HumansCells
    2. Wang D, Fu B, Peng Z, Yang D, Han M, Li M, Yang Y, Yang T, Sun L, Li W, Shi W, Yao X, Ma Y, Xu F, Wang X, Chen J, Xia D, Sun Y, Dong L, Wang J, Zhu X, Zhang M, Zhou Y, Pan A, Hu X, Mei X, Wei H, Xu X. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial. Front Med. 2021 Jun; 15(3):486-494. PMID: 33687643.
      Citations: 10     Fields:    Translation:Humans
    3. Zhou Y, Zhang J, Wang D, Wang D, Guan W, Qin J, Xu X, Fang J, Fu B, Zheng X, Wang D, Zhao H, Chen X, Tian Z, Xu X, Wang G, Wei H. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J Autoimmun. 2021 03; 118:102596. PMID: 33540371.
      Citations: 5     Fields:    Translation:Humans
    4. Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients. Proc Natl Acad Sci U S A. 2020 12 08; 117(49):30898-30899. PMID: 33203670.
      Citations:    Fields:    Translation:Humans
    5. Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30027-30028. PMID: 33184171.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Zhou Y, Wei H. Tocilizumab is recommended for the treatment of severe COVID-19. EBioMedicine. 2020 11; 61:103045. PMID: 33038768.
      Citations: 1     Fields:    Translation:Humans
    7. Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020 05 19; 117(20):10970-10975. PMID: 32350134.
      Citations: 963     Fields:    Translation:HumansCellsPHPublic Health